stella
beta
The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1 — Stella
Recruiting
Back to Empagliflozin in Cardiorenal Syndrome Type 1 trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
Thailand
Faculty of Medicine, Chulalongkorn University, Bangkok, Pathumwan
View full record on ClinicalTrials.gov